Intercept Pharma Stock Price (NASDAQ:ICPT)

Add to My Stocks
$95.75 $0.87 (0.92%) ICPT stock closing price Sep 18, 2017 (Closing)
Prev Close* : $94.88
Market Cap:
Day Low: $95.06
52 Week Low: $85.88
Open: $95.16
Volume: 1253922
Day High: $98
52 Week High: $172.95

Latest Stock Market News

Latest Articles

Intercept Pharma News - From Partners

S&P Joins the Party   by Zacks on Aug 08, 2017

ICPT Stockcharts

View ICPT PE ratio, PS ratio stocks charts and compare with peers.
ICPT Chart
Note: Compare Intercept Pharma stock price history with the index and industry peers.

Intercept Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Intercept Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

ICPT Industry Peers

Company Price Change (%)
The Medicines Company (MDCO)34.611.45 (4.37%)
Prothena (PRTA)64.630.12 (0.19%)
Enanta Pharma (ENTA)44.920.14 (0.31%)
Tobira Therapeutics Inc (TBRA)42.090 (0%)
Galectin Therapeutics (GALT)1.680.07 (4%)
Conatus Pharma (CNAT)5.690.25 (4.21%)
Fibrogen (FGEN)52.750.35 (0.67%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Arbutus Biopharma (ABUS)5.650.65 (13%)
Clovis Oncology (CLVS)76.747.28 (10.48%)
Athersys (ATHX)2.380.16 (7.21%)
Vericel Corp (VCEL)4.850.3 (6.59%)
AVEO Pharmaceuticals (AVEO)3.770.22 (6.2%)
Pluristem Therapeutics (PSTI)1.420.08 (5.97%)
Idera Pharma (IDRA)2.230.12 (5.69%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 19, 2017
CompanyPriceChange (%)
Organovo (ONVO)1.990.13 (6.13%)
BioDelivery Sciences (BDSI)2.70.15 (5.26%)
NewLink Genetics (NLNK)12.090.58 (4.58%)
Ultragenyx Pharma (RARE)52.992.24 (4.06%)
Retrophin (RTRX)23.190.89 (3.7%)
Momenta Pharma (MNTA)16.950.65 (3.69%)
Mirati Therapeutics (MRTX)10.80.4 (3.57%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 19, 2017

Intercept Pharmaceuticals Inc Stock News - Partner Headlines

Intercept Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues24.95M2.78M1.74M1.62M2.44M
Net Income-412.83M-226.42M-283.22M-67.79M-43.64M
Total Operating Expense427.48M231.93M114.91M41.07M21.35M
View Intercept Pharma income statement
balance sheet20162015201420132012
Total Assets739.25M655.75M254.14M150.31M112.17M
Total Liabilities424.32M53.6M23.25M67.91M46.26M
Shareholders Equity314.93M602.14M230.89M82.4M65.91M
View Intercept Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities8.43M21.34M0.69M0.17M-0.59M
Net Cash from (used by) Operating Activities-342.44M-162.9M-87.73M-28M-15.74M
Increase (Decrease) in Prop Plant And Equipment-5.07M-5.93M-4.64M-1.62M-0.03M
View Intercept Pharma cash flow statement

Intercept Pharma Stock Message Board

As of last trading day, Intercept Pharma stock price was 95.75. Intercept Pharma market capitalization is 2.38B and it represents the total market value of ICPT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Intercept Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Intercept Pharma is worth a lot, it will most likely be reflected in an inflated Intercept Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1253922 ICPT shares were traded yesterday, and Intercept Pharma stock chart shows that the ICPT stock quote hit a day high of 98 and day low of 95.06. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Intercept Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.